Skip to main content
Top
Published in: Clinical and Experimental Medicine 4/2016

Open Access 01-11-2016 | Original Article

Accumulation of CD5+CD19+ B lymphocytes expressing PD-1 and PD-1L in hypertrophied pharyngeal tonsils

Authors: Paulina Wlasiuk, Artur Niedzielski, Katarzyna Skorka, Agnieszka Karczmarczyk, Joanna Zaleska, Malgorzata Zajac, Maciej Putowski, Elzbieta Pac-Kozuchowska, Krzysztof Giannopoulos

Published in: Clinical and Experimental Medicine | Issue 4/2016

Login to get access

Abstract

Programmed death-1 (PD-1) is one of the most important inhibitory co-receptors expressed predominantly on activated T and B lymphocytes whose expression could be sustained by permanent antigenic stimulation accompanying chronic or recurrent tonsillitis. The expression of PD-1 and PD-1L was analyzed using flow cytometry on hypertrophied tonsils collected from 57 children. We observed high expression of PD-1 and PD-1L on certain lymphocytes subpopulations of hypertrophied tonsils; among T cells, the expression of PD-1 on protein level was higher on CD4+ cells (70.3 %) than on CD8+ cells (35 %). Interestingly, a limited expression of PD-1 was observed on CD19+ B lymphocytes (6.5 %), while CD5+CD19+ B cells overexpressed PD-1 (52.5 %). Moreover, the expression of PD-1L was also higher on CD5+CD19+ B cells (16.5 %) than on CD19+ B cells (3.5 %) and on CD4+ T cells (20 %) than on CD8+ T cells (10 %). PD-1 and PD-1L expressions correlated only on CD5+CD19+ cells. In conclusion, high expression of PD-1 and PD-1L on T and B cells could represent hallmark of immune system adaptation to chronic antigenic exposition in patients with tonsillitis.
Literature
2.
go back to reference van Kempen MJ, Rijkers GT, Van Cauwenberge PB. The immune response in adenoids and tonsils. Int Arch Allergy Immunol. 2000;122:8–19.CrossRefPubMed van Kempen MJ, Rijkers GT, Van Cauwenberge PB. The immune response in adenoids and tonsils. Int Arch Allergy Immunol. 2000;122:8–19.CrossRefPubMed
5.
go back to reference Balkhi MY, Qiangzhong M, Ahmad S, Junghans RP. T cell exhaustion and interleukin 2 downregulation. Cytokine. 2015;71:339–47.CrossRefPubMed Balkhi MY, Qiangzhong M, Ahmad S, Junghans RP. T cell exhaustion and interleukin 2 downregulation. Cytokine. 2015;71:339–47.CrossRefPubMed
6.
go back to reference Shinohara T, Taniwaki M, Ishida Y, Kawaichi M, Honjo T. Structure and chromosomal localization of the human PD-1 gene (PDCD1). Genomics. 1994;23:704–6.CrossRefPubMed Shinohara T, Taniwaki M, Ishida Y, Kawaichi M, Honjo T. Structure and chromosomal localization of the human PD-1 gene (PDCD1). Genomics. 1994;23:704–6.CrossRefPubMed
8.
9.
go back to reference James ES, Harney S, Wordsworth BP, Cookson WO, Davis SJ, Moffatt MF. PDCD1: tissue-specific susceptibility locus for inherited inflammatory disorders. Genes Immun. 2005;6:430–7.CrossRefPubMed James ES, Harney S, Wordsworth BP, Cookson WO, Davis SJ, Moffatt MF. PDCD1: tissue-specific susceptibility locus for inherited inflammatory disorders. Genes Immun. 2005;6:430–7.CrossRefPubMed
11.
go back to reference Brambilla I, Pusateri A, Pagella F, et al. Adenoids in children: advances in immunology, diagnosis and surgery. Clin Anat. 2014;27:346–52.CrossRefPubMed Brambilla I, Pusateri A, Pagella F, et al. Adenoids in children: advances in immunology, diagnosis and surgery. Clin Anat. 2014;27:346–52.CrossRefPubMed
12.
go back to reference Graeme-Cook F, Bhan AK, Harris NL. Immunohistochemical characterization of intraepithelial and subepithelial mononuclear cells of the upper airways. Am J Pathol. 1993;143:1416–21.PubMedPubMedCentral Graeme-Cook F, Bhan AK, Harris NL. Immunohistochemical characterization of intraepithelial and subepithelial mononuclear cells of the upper airways. Am J Pathol. 1993;143:1416–21.PubMedPubMedCentral
13.
go back to reference Dalloul A. CD5: a safeguard against autoimmunity and a shield for cancer cells. Autoimmun Rev. 2009;8:349–53.CrossRefPubMed Dalloul A. CD5: a safeguard against autoimmunity and a shield for cancer cells. Autoimmun Rev. 2009;8:349–53.CrossRefPubMed
14.
go back to reference Hayakawa K, Formica AM, Colombo MJ, Ichikawa D, Shinton SA, Brill-Dashoff J, Hardy RR. B cells generated by B-1 development can progress to chronic lymphocytic leukemia. Ann N Y Acad Sci. 2015. doi:10.1111/nyas.12768. Hayakawa K, Formica AM, Colombo MJ, Ichikawa D, Shinton SA, Brill-Dashoff J, Hardy RR. B cells generated by B-1 development can progress to chronic lymphocytic leukemia. Ann N Y Acad Sci. 2015. doi:10.​1111/​nyas.​12768.
15.
go back to reference Bouaziz JD, Yanaba K, Tedder TF. Regulatory B cells as inhibitors of immune responses and inflammation. Immunol Rev. 2008;224:201–14.CrossRefPubMed Bouaziz JD, Yanaba K, Tedder TF. Regulatory B cells as inhibitors of immune responses and inflammation. Immunol Rev. 2008;224:201–14.CrossRefPubMed
16.
go back to reference Mauri C, Menon M. The expanding family of regulatory B cells. Int Immunol. 2015. pii: dxv038. Mauri C, Menon M. The expanding family of regulatory B cells. Int Immunol. 2015. pii: dxv038.
17.
go back to reference Nicholas KJ, Zern EK, Barnett L, et al. B cell responses to HIV antigen are a potent correlate of viremia in HIV-1 infection and improve with PD-1 blockade. PLoS ONE. 2013;. doi:10.1371/journal.pone.0084185. Nicholas KJ, Zern EK, Barnett L, et al. B cell responses to HIV antigen are a potent correlate of viremia in HIV-1 infection and improve with PD-1 blockade. PLoS ONE. 2013;. doi:10.​1371/​journal.​pone.​0084185.
18.
go back to reference Siewe B, Wallace J, Rygielski S, et al. Regulatory B cells inhibit cytotoxic T lymphocyte (CTL) activity and elimination of infected CD4 T cells after in vitro reactivation of HIV latent reservoirs. PLoS ONE. 2014;9:e92934.CrossRefPubMedPubMedCentral Siewe B, Wallace J, Rygielski S, et al. Regulatory B cells inhibit cytotoxic T lymphocyte (CTL) activity and elimination of infected CD4 T cells after in vitro reactivation of HIV latent reservoirs. PLoS ONE. 2014;9:e92934.CrossRefPubMedPubMedCentral
20.
go back to reference Zhang G, Li N, Zhang P, et al. PD-1 mRNA expression is associated with clinical and viral profile and PD1 3′-untranslated region polymorphism in patients with chronic HBV infection. Immunol Lett. 2014;1:212–6.CrossRef Zhang G, Li N, Zhang P, et al. PD-1 mRNA expression is associated with clinical and viral profile and PD1 3′-untranslated region polymorphism in patients with chronic HBV infection. Immunol Lett. 2014;1:212–6.CrossRef
21.
go back to reference Dong H, Strome SE, Salomao DR, et al. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med. 2002;8:793–800.CrossRefPubMed Dong H, Strome SE, Salomao DR, et al. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med. 2002;8:793–800.CrossRefPubMed
22.
go back to reference Ishida M, Iwai Y, Tanaka Y, et al. Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissues. Immunol Lett. 2002;84:57–62.CrossRefPubMed Ishida M, Iwai Y, Tanaka Y, et al. Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissues. Immunol Lett. 2002;84:57–62.CrossRefPubMed
23.
go back to reference Speiser DE, Utzschneider DT, Oberle SG, Münz C, Romero P, Zehn D. T cell differentiation in chronic infection and cancer: functional adaptation or exhaustion? Nat Rev Immunol. 2014;. doi:10.1038/nri3740.PubMed Speiser DE, Utzschneider DT, Oberle SG, Münz C, Romero P, Zehn D. T cell differentiation in chronic infection and cancer: functional adaptation or exhaustion? Nat Rev Immunol. 2014;. doi:10.​1038/​nri3740.PubMed
24.
go back to reference Lyford-Pike S, Peng S, Young GD, et al. Evidence for a role of the PD-1:PD-L1 pathway in immune resistance of HPV-associated head and neck squamous cell carcinoma. Cancer Res. 2013;73:1733–41.CrossRefPubMedPubMedCentral Lyford-Pike S, Peng S, Young GD, et al. Evidence for a role of the PD-1:PD-L1 pathway in immune resistance of HPV-associated head and neck squamous cell carcinoma. Cancer Res. 2013;73:1733–41.CrossRefPubMedPubMedCentral
25.
go back to reference Wu X, Zhang H, Xing Q, et al. PD-1(+) CD8(+) T cells are exhausted in tumours and functional in draining lymph nodes of colorectal cancer patients. Br J Cancer. 2014;111:1391–9.CrossRefPubMedPubMedCentral Wu X, Zhang H, Xing Q, et al. PD-1(+) CD8(+) T cells are exhausted in tumours and functional in draining lymph nodes of colorectal cancer patients. Br J Cancer. 2014;111:1391–9.CrossRefPubMedPubMedCentral
Metadata
Title
Accumulation of CD5+CD19+ B lymphocytes expressing PD-1 and PD-1L in hypertrophied pharyngeal tonsils
Authors
Paulina Wlasiuk
Artur Niedzielski
Katarzyna Skorka
Agnieszka Karczmarczyk
Joanna Zaleska
Malgorzata Zajac
Maciej Putowski
Elzbieta Pac-Kozuchowska
Krzysztof Giannopoulos
Publication date
01-11-2016
Publisher
Springer International Publishing
Published in
Clinical and Experimental Medicine / Issue 4/2016
Print ISSN: 1591-8890
Electronic ISSN: 1591-9528
DOI
https://doi.org/10.1007/s10238-015-0385-y

Other articles of this Issue 4/2016

Clinical and Experimental Medicine 4/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine